We have observed upregulation of PRR processing in both prostate [5] and breast cancer [23], however, another group has shown that sPRR levels are elevated in patients with pancreatic ductal adenocarcinoma (PDAC) and correlate with the clinical severity of the cancer [41]. This evidence concerns the gene ATP6AP2 and pancreatic ductal adenocarcinoma.